CURE

CNQ:CURE

Biocure Technology Inc.

  • Stock

CAD

Last Close

0.02

11/09 13:30

Market Cap

1.22M

Beta: 2.30

PE Ratio

0.64

PFCF: −3.18

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
15.28K
-
25.64K
67.74%
16.12K
37.11%
8.02K
50.28%
4.27K
46.69%
2.03K
52.57%
average payables
57.64K
-
52.60K
8.75%
66.45K
26.33%
153.02K
130.27%
479.06K
213.07%
880.89K
83.88%
1.71M
94.12%
1.61M
5.68%
783.46K
51.42%
average receivables
20.92K
-
12.16K
41.88%
14.56K
19.77%
53.23K
265.47%
61.23K
15.04%
60.67K
0.92%
79.76K
31.47%
987.20K
1,137.74%
962.80K
2.47%
book value per share
0.06
-
0.05
16.70%
-0.01
113.54%
0.03
583.07%
0.01
69.49%
-0.00
131.86%
-0.02
581.01%
-0.01
74.68%
-0.02
257.99%
capex per share
-0.00
-
-0.00
119.38%
-0.01
123.72%
-0.01
10.48%
-0.00
99.73%
-0.00
31.04%
capex to depreciation
-7.39
-
-14.51
96.40%
-18.09
24.67%
-23.42
29.44%
-0.05
99.78%
-0.05
1.76%
capex to operating cash flow
0.07
-
0.22
227.77%
0.36
66.45%
0.39
7.87%
0.00
99.44%
0.00
66.39%
capex to revenue
-15.14
-
cash per share
0.00
-
0.00
61.40%
0.02
105,230.01%
0.01
41.45%
0.00
90.23%
0.00
20.49%
0.00
65.19%
0.00
224.65%
0.00
77.18%
days of inventory on hand
7.13K
-
days payables outstanding
245.78K
-
days sales outstanding
1.07K
-
debt to assets
0.01
-
0.02
276.23%
0.35
1,329.78%
0.12
66.03%
0.48
300.49%
0.80
66.00%
0.88
9.92%
0.91
4.04%
0.04
95.73%
debt to equity
0.01
-
0.03
293.18%
-1.34
5,151.28%
0.16
112.08%
1.93
1,096.07%
-12.56
749.86%
-1.99
84.14%
-7.12
257.25%
-0.04
99.42%
dividend yield
earnings yield
0.11
-
-0.21
297.97%
-4.66
2,080.44%
-0.16
96.62%
-0.14
9.00%
-0.23
63.36%
-0.12
49.56%
-0.38
222.26%
-1.08
184.56%
enterprise value
352.04K
-
439.46K
24.83%
-54.87K
112.49%
29.73M
54,290.20%
47.61M
60.14%
24.36M
48.84%
30.93M
26.99%
17.03M
44.96%
1.11M
93.46%
enterprise value over ebitda
-4.16
-
-5.34
28.25%
0.03
100.52%
-6.29
22,803.52%
-7.44
18.21%
-5.35
28.04%
-10.64
98.74%
-64.99
510.77%
-1.61
97.52%
ev to operating cash flow
-11.17
-
-11.93
6.86%
0.04
100.35%
-15.83
37,677.35%
-18.39
16.15%
-9.08
50.64%
-23.61
160.08%
-15.72
33.44%
-1.36
91.35%
ev to sales
-9.60
-
free cash flow per share
-0.00
-
-0.00
1.72%
-0.03
3,304.81%
-0.02
23.57%
-0.04
50.38%
-0.04
4.56%
-0.01
65.26%
-0.01
21.13%
-0.01
27.46%
free cash flow yield
-0.09
-
-0.09
1.72%
-3.20
3,304.81%
-0.08
97.65%
-0.08
1.82%
-0.18
133.45%
-0.05
72.84%
-0.08
66.84%
-0.77
843.00%
graham net net
-0.00
-
-0.00
172.01%
-0.01
232.88%
0.00
117.18%
-0.03
1,597.22%
-0.05
83.41%
-0.07
39.51%
-0.03
51.88%
-0.04
22.90%
graham number
0.04
-
0.05
28.42%
0.08
71.81%
0.19
130.40%
0.12
35.97%
0.06
51.71%
0.12
109.61%
0.08
37.90%
0.07
11.48%
income quality
-0.86
-
0.44
151.38%
0.65
46.42%
0.39
39.10%
0.39
0.00%
0.56
42.49%
0.43
24.01%
0.94
121.78%
2.03
114.92%
intangibles to total assets
0
-
0
0
0
0.00
Infinity%
0.00
36.15%
0.00
10.11%
0.00
15.42%
0
100%
interest coverage
71.37
-
67.37
5.61%
-64.45
195.67%
-166.98
159.10%
-169.91
1.76%
-33.56
80.25%
-12.34
63.24%
-0.68
94.49%
-79.79
11,647.79%
interest debt per share
0.00
-
0.00
207.65%
0.01
622.80%
0.01
42.87%
0.02
251.34%
0.04
110.25%
0.04
10.33%
0.04
3.46%
0.00
98.06%
inventory turnover
0.05
-
invested capital
0.01
-
0.03
293.18%
-1.34
5,151.28%
0.16
112.08%
1.93
1,096.07%
-12.56
749.86%
-1.99
84.14%
-7.12
257.25%
-0.04
99.42%
market cap
340.70K
-
391.30K
14.85%
433.42K
10.77%
30.35M
6,902.59%
45.98M
51.49%
20.84M
54.67%
26.99M
29.50%
13.40M
50.37%
1.07M
92.02%
net current asset value
-36.42K
-
-119.97K
229.38%
-444.36K
270.41%
361.17K
181.28%
-2.54M
803.59%
-4.76M
87.23%
-6.73M
41.43%
-2.87M
57.32%
-4.29M
49.51%
net debt to ebitda
-0.13
-
-0.59
336.35%
0.25
142.17%
0.13
46.99%
-0.26
295.18%
-0.77
202.91%
-1.36
75.45%
-13.86
921.45%
-0.06
99.55%
net income per share
0.00
-
-0.00
297.97%
-0.05
2,080.44%
-0.05
9.89%
-0.07
34.40%
-0.05
26.83%
-0.03
35.48%
-0.05
52.34%
-0.01
78.11%
operating cash flow per share
-0.00
-
-0.00
1.72%
-0.03
3,092.62%
-0.02
33.07%
-0.03
34.41%
-0.03
2.42%
-0.01
51.77%
-0.01
21.24%
-0.01
27.20%
payables turnover
0.00
-
receivables turnover
0.34
-
research and ddevelopement to revenue
55.56
-
return on tangible assets
0.02
-
-0.04
327.42%
-1.92
4,458.93%
-1.23
36.00%
-1.82
47.61%
-1.07
41.35%
-0.70
34.33%
-1.23
75.23%
-0.56
54.74%
revenue per share
0.00
-
roe
0.02
-
-0.05
337.67%
7.29
16,206.31%
-1.66
122.75%
-7.31
340.59%
16.78
329.64%
1.59
90.53%
9.57
501.73%
0.58
93.89%
roic
-0.01
-
0.13
1,199.60%
-21.22
16,535.62%
-1.42
93.31%
-2.48
74.48%
-1.39
43.79%
-1.53
9.80%
-0.46
69.82%
0.60
230.57%
sales general and administrative to revenue
113.93
-
shareholders equity per share
0.06
-
0.05
16.70%
-0.01
113.54%
0.03
583.07%
0.01
69.49%
-0.00
131.86%
-0.02
581.01%
-0.01
74.68%
-0.02
257.99%
stock based compensation to revenue
tangible asset value
1.93M
-
1.85M
4.33%
-276.75K
115.00%
2.88M
1,140.83%
899.28K
68.78%
-418.87K
146.58%
-2.32M
452.88%
-853.44K
63.15%
-2.33M
172.74%
tangible book value per share
0.06
-
0.05
16.70%
-0.01
113.54%
0.03
583.07%
0.01
69.49%
-0.00
145.75%
-0.02
447.85%
-0.01
64.92%
-0.02
163.20%
working capital
-36.42K
-
-119.97K
229.38%
203.46K
269.60%
361.17K
77.51%
-1.73M
577.89%
-1.98M
14.60%
-3.81M
92.39%
-1.62M
57.48%
-4.29M
165.36%

All numbers in CAD (except ratios and percentages)